The FDA has approved the FreeStyle Libre Flash Glucose Monitoring System, a continuous glucose monitoring system for adults not requiring blood samples calibration. The system is available from Abbott Diabetes Care Inc., Abbott Park, IL, and can be used by adult patients with diabetes to make diabetes treatment decisions without calibration using a blood sample from the fingertip.
The system reduces the need for “fingerstick” testing by using a small sensor wire inserted below the skin’s surface that continuously measures and monitors glucose levels. Users can determine glucose levels by waving a dedicated, mobile reader above the sensor wire to determine if glucose levels are too high to too low, and how glucose levels are changing. After a 12-hour start-up period, the device can be worn for up to 10 days.
US Food and Drug Administration. FDA approves first continuous glucose monitoring system for adults not requiring blood sample calibration. FDA Web site. September 27, 2017. https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm577890.htm. Accessed October 1, 2017.
This Week's Must Reads
Adherence Rates to Secondary Prevention Meds, Circulation; ePub 2018 Jan 31; Mathews, et al
Low-Dose CT Screening for Lung Cancer, CHEST; ePub 2018 Jan 25; Mazzone, et al
Catheter Ablation for AF in Patients with HF, N Engl J Med; 2018 Feb 1; Marrouche, et al
Changes in Physical Activity & Risk of HF, Circulation; ePub 2018 Jan 31; Florido, et al
Should Patients with Syncope be Evaluated for PE?, JAMA Intern Med; ePub 2018 Jan 29; Costantino, et al
Must Reads in Diabetes
Risk of Infection in People with Diabetes, Diabetes Care; ePub 2018 Jan 12; Carey, et al
Empagliflozin Use in Patients with T2D, CVD & CKD, Circulation; 2018 Jan; Wanner, Lachin, et al
Adding Ezetimibe to Statin Therapy in Diabetes, Circulation; ePub 2017 Dec 20; Giugliano, et al
FDA Approves Steglatro for Adults with T2D, Pfizer news release; 2017 Dec 22
Adding Sotagliflozin to Insulin in T1D Patients, N Engl J Med; 2017 Dec 14; Garg, Henry, et al